aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate

Benzinga · 1d ago
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from the same period last year.